Global Tumor Marker Market Analyzed by VPG in New In-Demand Report Now Available at

London, UK (PRWEB) December 24, 2012

Tumor markers form one of the most important segments of the world cancer diagnostics industry. Recently, the tumor marker market growth has picked up given the enhancing number of cancer affected people and rising cancer mortality. In 2010, the market was evaluated at approximately USD 1 billion. It is likely to grow at a CARG of above 5.5% in 2012-2017. Abbott, Hoffmann-La Roche, Beckman Coulter, Fujirebio Inc. and bioM

This entry was posted in Review and tagged , , , , , , , , . Bookmark the permalink.

Leave a Reply